- United States
- /
- Biotech
- /
- NasdaqGS:DVAX
High Growth Tech Stocks In The United States With Promising Potential
Reviewed by Simply Wall St
Over the last 7 days, the United States market has remained flat, yet it has experienced a robust 38% increase over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks with promising potential involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these favorable conditions.
Top 10 High Growth Tech Companies In The United States
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Super Micro Computer | 20.86% | 27.98% | ★★★★★★ |
Sarepta Therapeutics | 23.67% | 43.83% | ★★★★★★ |
TG Therapeutics | 28.39% | 43.54% | ★★★★★★ |
Invivyd | 42.91% | 70.39% | ★★★★★★ |
Ardelyx | 27.19% | 66.44% | ★★★★★★ |
AsiaFIN Holdings | 60.53% | 81.55% | ★★★★★★ |
Amicus Therapeutics | 20.33% | 62.45% | ★★★★★★ |
Travere Therapeutics | 27.74% | 70.00% | ★★★★★★ |
Seagen | 22.57% | 71.80% | ★★★★★★ |
ImmunoGen | 26.00% | 45.85% | ★★★★★★ |
Click here to see the full list of 249 stocks from our US High Growth Tech and AI Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Dynavax Technologies (NasdaqGS:DVAX)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that develops and commercializes vaccines in the United States, with a market cap of $1.43 billion.
Operations: Dynavax Technologies focuses on the discovery, development, and commercialization of novel vaccines in the U.S., generating $249.69 million in revenue from this segment.
Dynavax Technologies, amidst a challenging biotech landscape, has demonstrated resilience with a notable 38.7% projected annual earnings growth, surpassing the US market average of 15.2%. This growth trajectory is underpinned by strategic R&D investments and an effective product portfolio expansion. Despite a slower revenue growth rate at 17.1% compared to the high-growth threshold of 20%, Dynavax's recent financial performance reveals robust gains with second-quarter revenue up to $73.8 million from $60.25 million year-over-year and net income rising to $11.39 million from $3.43 million in the same period last year—signs that operational efficiencies are taking hold effectively within its core markets.
Tripadvisor (NasdaqGS:TRIP)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: TripAdvisor, Inc. operates as an online travel company offering travel guidance products and services globally, with a market capitalization of approximately $2.15 billion.
Operations: TripAdvisor generates revenue through three main segments: Viator, Thefork, and Brand Tripadvisor, with Brand Tripadvisor contributing the largest share at $998 million. The company also incurs costs related to corporate activities and eliminations totaling -$138 million.
Tripadvisor, amidst a challenging travel industry landscape, has pivoted towards innovative content platforms like Destination: Space to capture new market segments. While the company's overall revenue growth is projected at a modest 6.1% annually, its earnings are expected to surge by 38.8% per year, outpacing the US market average of 15.2%. This growth is supported by strategic R&D investments which have enabled Tripadvisor to diversify its offerings and enhance user engagement significantly. Despite facing downward pressures on margins and experiencing moderate sales growth in traditional segments, Tripadvisor’s recent share repurchase of $49.94 million underscores a commitment to shareholder value and confidence in its strategic direction.
- Dive into the specifics of Tripadvisor here with our thorough health report.
Assess Tripadvisor's past performance with our detailed historical performance reports.
Western Digital (NasdaqGS:WDC)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Western Digital Corporation is a global company that develops, manufactures, and sells data storage devices and solutions across various regions including the United States, China, Europe, and more, with a market cap of approximately $23.02 billion.
Operations: The company generates revenue primarily from Hard Disk Drives (HDD) and Flash-Based Products, with the latter slightly leading at $6.69 billion compared to HDD's $6.32 billion.
Western Digital, amidst a transformative tech landscape, is pushing the boundaries of HDD capacity with its latest 32TB UltraSMR and 26TB CMR drives, addressing the burgeoning demand for high-capacity data storage critical in AI data cycles. These innovations not only highlight Western Digital's prowess in enhancing storage solutions but also position it advantageously as data reliance grows across industries. The company's strategic R&D investment has fostered these technological advancements, evident from its recent product launches that promise to optimize data center efficiency and lower total cost of ownership (TCO). This focus on high-capacity and energy-efficient storage solutions could be pivotal as enterprises increasingly prioritize sustainability alongside performance in their operational needs.
- Navigate through the intricacies of Western Digital with our comprehensive health report here.
Understand Western Digital's track record by examining our Past report.
Where To Now?
- Unlock more gems! Our US High Growth Tech and AI Stocks screener has unearthed 246 more companies for you to explore.Click here to unveil our expertly curated list of 249 US High Growth Tech and AI Stocks.
- Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
- Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:DVAX
Dynavax Technologies
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States.
Reasonable growth potential with adequate balance sheet.